These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
North Carolina
|
47-3414576
|
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.)
|
|
4521 Sharon Road, Suite 407, Charlotte, NC
|
28211
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
☐
|
|
Accelerated filer
☐
|
|
Non-accelerated filer
☐
|
|
Smaller reporting company
☑
|
|
|
|
Emerging growth company
☑
|
|
|
|
Page
|
|
|
|
No
|
|
|
|
|
|
|
PART I - FINANCIAL INFORMATION
|
|
|
|
|
|
|
ITEM 1.
|
Financial Statements
.
|
3
|
|
|
|
|
|
ITEM 2.
|
Management's Discussion and Analysis of Financial Condition and
Results of Operations.
|
30
|
|
|
|
|
|
ITEM 3.
|
Quantitative and Qualitative Disclosures About Market
Risk.
|
37
|
|
|
|
|
|
ITEM 4.
|
Controls and Procedures.
|
37
|
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
|
ITEM 1.
|
Legal Proceedings.
|
38
|
|
|
|
|
|
ITEM 1A.
|
Risk Factors.
|
38
|
|
|
|
|
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of
Proceeds.
|
38
|
|
|
|
|
|
ITEM 3.
|
Defaults Upon Senior Securities.
|
38
|
|
|
|
|
|
ITEM 4.
|
Mine Safety Disclosures.
|
38
|
|
|
|
|
|
ITEM 5.
|
Other Information.
|
38
|
|
|
|
|
|
ITEM 6.
|
Exhibits.
|
39
|
|
|
●
|
our material dependence on our relationships with
kathy
ireland®
Worldwide and
certain of its affiliates;
|
|
|
●
|
our limited operating history;
|
|
|
●
|
the limited operating histories of our subsidiaries;
|
|
|
●
|
our history of losses;
|
|
|
●
|
risks associated with any failure by us to maintain an effective
system of internal control over financial reporting;
|
|
|
●
|
the terms of various agreements with
kathy ireland®
Worldwide and possible impacts on our
management's abilities to make certain decisions regarding the
operations of our company;
|
|
|
●
|
our dependence on consumer spending patterns;
|
|
|
●
|
our history on reliance on sales from a limited number of
customers, including a related party;
|
|
|
●
|
risks associated with our failure to effectively promote our
brands;
|
|
|
●
|
our ability to identify and successfully acquire additional brands
and trademarks;
|
|
|
●
|
the operating agreements of our I'M1 and EE1
subsidiaries;
|
|
|
●
|
the accounting treatment of securities we accept as partial
compensation for services;
|
|
|
●
|
our ability to liquidate those securities and the possible impact
of the Investment Company Act of 1940;
|
|
|
●
|
the possible need to raise additional capital in the
future;
|
|
|
●
|
terms of the contracts with third parties in each of our
divisions;
|
|
|
●
|
possible conflicts of interest with
kathy ireland®
Worldwide;
|
|
|
●
|
possible litigation involving our licensed products;
|
|
|
●
|
our ability to effectively compete and our dependence on market
acceptance of our brands;
|
|
|
●
|
the lack of long-term contracts for the purchase of products from
our professional products division;
|
|
|
●
|
our ability to protect our intellectual property;
|
|
|
●
|
additional operational risks associated with our professional
products division;
|
|
|
●
|
risks associated with developing a liquid market for our common
stock and possible future volatility in its trading
price;
|
|
|
● |
risks associated with any future failure to satisfy the NYSE
American LLC continued listing standards;
|
|
|
●
|
dilution to our shareholders from the exercise of outstanding
options and warrants and the vesting of restricted stock
awards;
|
|
|
● |
risks associated with our status as an emerging growth
company;
|
|
|
● |
risks associated with control by our executive officers, directors
and affiliates;
|
|
|
● |
risks associated with unfavorable research reports;
|
|
|
● |
risks associated with our status as a public company;
and
|
|
|
●
|
risks associated with North Carolina law.
|
|
|
(Unaudited)
|
|
|
|
December 31,
|
September 30,
|
|
|
2017
|
2017
|
|
Assets
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
Cash
and cash equivalents
|
$
8,817,856
|
$
284,246
|
|
Accounts
receivable
|
65,728
|
141,462
|
|
Accounts
receivable -- related party
|
-
|
712,325
|
|
Accounts
receivable other
|
50,052
|
12,440
|
|
Accounts
receivable other – related party
|
290,909
|
236,364
|
|
Marketable
securities
|
299,000
|
-
|
|
Investment
other securities
|
1,159,112
|
859,112
|
|
Investment
other securities – related party
|
200,000
|
-
|
|
Note
receivable – related party
|
268,373
|
276,375
|
|
Inventory
|
593,149
|
588,197
|
|
Deferred
initial public offering costs
|
-
|
497,735
|
|
Prepaid
expenses and other current assets
|
306,964
|
85,420
|
|
Total current assets
|
12,051,143
|
3,693,676
|
|
|
|
|
|
Other
assets:
|
|
|
|
Property
and equipment, net
|
56,125
|
135,476
|
|
Intangible
assets, net
|
3,191,725
|
3,240,287
|
|
Total other assets
|
3,247,850
|
3,375,763
|
|
|
|
|
|
Total assets
|
$
15,298,993
|
$
7,069,439
|
|
Liabilities and shareholders' (deficit) equity
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$
168,645
|
$
397,601
|
|
Accounts
payable related party
|
8,199
|
67,879
|
|
Deferred
revenue
|
49,125
|
41,417
|
|
Accrued payroll
|
364,515
|
-
|
|
Accrued
expenses
|
165,148
|
123,823
|
|
Accrued
expenses to related party
|
12,800
|
892,805
|
|
Total current liabilities
|
768,432
|
1,523,525
|
|
|
|
|
|
Long
term liabilities
|
|
|
|
Long
term liabilities, to related party
|
360,000
|
360,000
|
|
Deferred
tax liability
|
15,000
|
37,000
|
|
Total
long term liabilities
|
375,000
|
397,000
|
|
|
|
|
|
Total liabilities
|
1,143,432
|
1,920,525
|
|
|
|
|
|
Level
Brands, Inc. shareholders' equity:
|
|
|
|
Preferred
stock, authorized 50,000,000 shares, $0.001 par value, no shares
issued and outstanding
|
-
|
-
|
|
Common
stock, authorized 150,000,000 shares, $0.001 par
value,
|
|
|
|
7,798,928
and 5,792,261 shares issued and outstanding,
respectively
|
7,799
|
5,792
|
|
Accumulated
other comprehensive income
|
33,500
|
-
|
|
Additional
paid in capital
|
20,699,403
|
10,463,480
|
|
Accumulated
deficit
|
(7,390,350
)
|
(6,257,421
)
|
|
Total Level Brands, Inc. shareholders' equity
|
13,350,352
|
4,211,851
|
|
Non-controlling
interest
|
805,209
|
937,063
|
|
Total shareholders' equity (deficit)
|
14,155,561
|
5,148,914
|
|
|
|
|
|
Total liabilities and shareholders' equity (deficit)
|
$
15,298,993
|
$
7,069,439
|
|
|
Three
Months Ended
|
Three
Months Ended
|
|
|
December
31,
|
December
31,
|
|
|
2017
|
2016
|
|
|
|
|
|
Sales
|
$
448,793
|
$
422,173
|
|
Sales
related party
|
254,545
|
-
|
|
Total
Gross Sales
|
703,338
|
422,173
|
|
Allowances
|
(15,582
)
|
(222,336
)
|
|
|
|
|
|
Net
Sales
|
433,211
|
199,837
|
|
Net
sales related party
|
254,545
|
-
|
|
Total Net Sales
|
687,756
|
199,837
|
|
|
|
|
|
Costs
of sales
|
228,124
|
162,746
|
|
Gross profit
|
459,632
|
37,091
|
|
Operating
expenses
|
1,687,644
|
600,266
|
|
Loss from
operations
|
(1,228,012
)
|
(563,175
)
|
|
Loss on disposal of property
and equipment
|
(69,511
)
|
|
|
Interest
expense
|
259
|
132,320
|
|
Loss before provision for
income taxes
|
(1,297,782
)
|
(695,495
)
|
|
Benefit
(Provision) for income taxes
|
33,000
|
(2,000
)
|
|
Net loss
|
(1,264,782
)
|
(697,495
)
|
|
Net
loss attributable to non-controlling interest
|
(131,854
)
|
(63,016
)
|
|
|
|
|
|
Net loss attributable to Level Brands, Inc. common
shareholders
|
$
(1,132,928
)
|
$
(634,479
)
|
|
|
|
|
|
Loss per share, basic and diluted
|
$
(0.16
)
|
$
(0.18
)
|
|
Weighted average number of shares outstanding
|
6,911,871
|
3,485,950
|
|
|
Three Months Ended
|
Three Months Ended
|
|
|
December 31,
|
December 31,
|
|
|
2017
|
2016
|
|
|
|
|
|
Net
loss
|
$
(1,264,782
)
|
$
(697,495
)
|
|
Other
Comprehensive Income:
|
|
|
|
Net
Unrealized Gain on Marketable Securities, net of tax
|
33,500
|
-
|
|
Comprehensive
Loss
|
$
(1,231,282
)
|
$
(697,495
)
|
|
|
|
|
|
Comprehensive
loss attributable to non-controlling interest
|
$
(131,854
)
|
$
(63,016
)
|
|
Comprehensive
loss attributable to Level Brands, Inc. common
shareholders
|
$
(1,099,428
)
|
$
(634,479
)
|
|
|
|
|
|
|
Three
Months Ended
December
31,
|
Three
Months Ended
December
31,
|
|
|
2017
|
2016
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
Net
loss
|
$
(1,264,782
)
|
$
(697,495
)
|
|
Adjustments to reconcile net loss to net
|
|
|
|
cash used by operating activities:
|
|
|
|
Stock
based compensation
|
17,114
|
9,672
|
|
Restricted
stock expense
|
39,100
|
39,101
|
|
Issuance
of stock / warrants for service
|
37,002
|
-
|
|
Amortization
of debt issue costs
|
-
|
79,774
|
|
Depreciation
and amortization
|
61,067
|
9,189
|
|
Loss
on sale of property and equipment
|
69,511
|
4,000
|
|
Common
stock issued as charitable contribution
|
-
|
17,000
|
|
Non-cash
consideration received for services
|
(454,503
)
|
-
|
|
Changes in operating assets and liabilities:
|
|
|
|
Accounts
receivable
|
75,734
|
2,620
|
|
Accounts
receivable – related party
|
712,325
|
-
|
|
Other
accounts receivable
|
(37,612
)
|
-
|
|
Other
accounts receivable – related party
|
(54,545
)
|
-
|
|
Note
receivable – related party
|
8,002
|
-
|
|
Inventory
|
(4,952
)
|
(19,572
)
|
|
Prepaid
expenses and other current assets
|
(221,545
)
|
26,832
|
|
Accounts
payable and accrued expenses
|
162,142
|
(49,739
)
|
|
Accounts
payable and accrued expenses – related party
|
(939,685
)
|
-
|
|
Interest
Payable
|
-
|
47,981
|
|
Deferred
revenue
|
7,708
|
-
|
|
Deferred
tax liability
|
(33,000
)
|
2,000
|
|
Cash
used by operating activities
|
(1,820,919
)
|
(528,637
)
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
Purchase
of investment other securities
|
(300,000
)
|
-
|
|
Purchase
of property and equipment
|
(2,665
)
|
(7,034
)
|
|
Cash
used by investing activities
|
(302,665
)
|
(7,034
)
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
Proceeds
from issuance of common stock
|
10,927,535
|
-
|
|
Proceeds
from convertible note
|
-
|
2,125,000
|
|
Debt
issuance costs
|
-
|
(200,800
)
|
|
Repayment
of line of credit
|
-
|
(300,000
)
|
|
Deferred
issuance costs
|
(270,341
)
|
-
|
|
Cash
provided by financing activities
|
10,657,194
|
1,624,200
|
|
Net
increase (decrease) in cash
|
8,533,610
|
1,088,529
|
|
Cash
and cash equivalents,
beginning
of period
|
284,246
|
34,258
|
|
Cash and cash equivalents,
end of period
|
$
8,817,856
|
$
1,122,787
|
|
|
|
|
|
|
Three Months ended
December 31,
|
Three Months Ended
December 31,
|
|
|
2017
|
2016
|
|
|
|
|
|
Cash
Payments for:
|
|
|
|
Interest
expense
|
$
259
|
$
4,565
|
|
|
|
|
|
Non-cash
financial activities:
|
|
|
|
Warrants
issued to IPO selling agent
|
$
171,600
|
$
-
|
|
IPO
costs incurred but unpaid as of quarter end
|
14,745
|
-
|
|
Common
stock issued for services
|
-
|
570,000
|
|
Warrants
issued with convertible notes
|
-
|
5,159
|
|
Noncontrolling
interest transfer
|
-
|
338,556
|
|
Strike
price adjustment on placement agent warrants
|
-
|
31,505
|
|
Common
stock issued for warrant exercise
|
-
|
85,950
|
|
Equity
issued to purchase membership interest in subsidiary
|
-
|
110,000
|
|
|
|
|
|
|
In Active Markets for Identical Assets and Liabilities
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
Total Fair Value at
December 31,
2017
|
|
|
|
|
|
|
|
Marketable
securities
|
$
299,000
|
-
|
$
-
|
$
299,000
|
|
Investment
other securities
|
-
|
-
|
$
1,359,112
|
$
1,359,112
|
|
|
|
|
|
|
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
Balance
at September 30, 2017
|
$
-
|
$
-
|
$
859,112
|
$
859,112
|
|
Receipt
of equity investment upon completion of contract
|
$
254,500
|
$
-
|
$
-
|
$
254,500
|
|
Receipt
of equity investment upon completion of contract
|
$
-
|
$
-
|
$
200,000
|
$
200,000
|
|
Purchase
of preferred shares, convertible into common stock
|
$
-
|
$
-
|
$
300,000
|
$
300,000
|
|
Change
in value of equity, other comprehensive income
|
$
44,500
|
$
-
|
$
-
|
$
44,500
|
|
Balance
at December 31, 2017
|
$
299,000
|
$
-
|
$
1,359,112
|
$
1,658,112
|
|
|
December 31,
|
September 30,
|
|
|
2017
|
2017
|
|
Finished
goods
|
$
383,036
|
$
375,459
|
|
Inventory
components
|
210,113
|
212,738
|
|
Inventory
reserve
|
-
|
-
|
|
Total
|
$
593,149
|
$
588,197
|
|
|
December 31,
|
September 30,
|
|
|
2017
|
2017
|
|
Computers
and equipment
|
$
39,926
|
$
37,261
|
|
Show
booth and equipment
|
49,123
|
171,986
|
|
Manufacturers’
molds and plates
|
34,200
|
34,200
|
|
|
123,249
|
243,447
|
|
Less
accumulated depreciation
|
(67,124
)
|
(107,971
)
|
|
Net
property and equipment
|
$
56,125
|
$
135,476
|
|
|
December 31,
|
September 30,
|
|
|
2017
|
2017
|
|
Trademark
and other intellectual property related to BPU
|
$
486,760
|
$
486,760
|
|
Trademark
and other intellectual property related to I’M1
|
971,667
|
971,667
|
|
Trademark
and other intellectual property related to EE1
|
471,667
|
471,667
|
|
Trademark, tradename and other intellectual
property related to kathy ireland®Health &
Wellness
™
,
net
|
800,000
|
830,000
|
|
Cash,
warrants and stock issued related to the Wholesale license
agreement with Chef Andre Carthen, net
|
295,298
|
307,146
|
|
Cash,
warrants and stock issued related to the Wholesale license
agreement with Nicholas Walker, net
|
166,333
|
173,047
|
|
Total
|
$
3,191,725
|
$
3,240,287
|
|
|
|
|
|
Intangible
|
Total unamortized cost
|
2018
|
2019
|
2020
|
2021
|
2022
|
thereafter
|
|
Trademark,
tradename and other intellectual property related to kathy
ireland® Health & Wellness™
|
$
800,000
|
$
90,000
|
$
120,000
|
$
120,000
|
$
120,000
|
$
120,000
|
$
230,000
|
|
Cash,
warrant and stock issued related to the Wholesale license agreement
with Chef Andre Carthen
|
$
295,298
|
$
32,446
|
$
44,294
|
$
44,294
|
$
44,294
|
$
44,294
|
$
85,676
|
|
Cash,
warrant and stock issued related to the Wholesale license agreement
with Nicholas Walker
|
$
166,333
|
$
17,402
|
$
24,950
|
$
24,950
|
$
24,950
|
$
24,950
|
$
48,297
|
|
|
2017
|
2016
|
|
Exercise
price
|
-
|
$
7.50
|
|
Risk
free interest rate
|
-
|
1.14%
- 1.42%
|
|
Volatility
|
-
|
54.69%
- 60.39%
|
|
Expected
term
|
-
|
5 -
7 years
|
|
Dividend
yield
|
-
|
None
|
|
|
2017
|
2016
|
|
Exercise
price
|
$
7.50
|
$
7.80
|
|
Risk
free interest rate
|
2.06
%
|
1.22%
- 1.27%
|
|
Volatility
|
43.12
%
|
52.77%
- 54.49%
|
|
Expected
term
|
5
years
|
5
years
|
|
Dividend
yield
|
None
|
None
|
|
|
Number of shares
|
Weighted-average
exercise price
|
Weighted-average remaining contractual term (in
years)
|
Aggregate intrinsic value
(in thousands)
|
|
Outstanding
at September 30, 2017
|
333,300
|
5.83
|
|
|
|
Granted
|
—
|
—
|
|
|
|
Exercised
|
—
|
—
|
|
|
|
Forfeited
|
20,000
|
2.00
|
|
|
|
Outstanding
at December 31, 2017
|
313,300
|
$
6.07
|
5.4
|
$
—
|
|
|
|
|
|
|
|
Exercisable
at December 31, 2017
|
285,800
|
$
5.72
|
—
|
$
—
|
|
|
Number of shares
|
Weighted-average
exercise price |
Weighted-
average remaining contractual term (in years)
|
Aggregate intrinsic value
(in thousands)
|
|
Outstanding
at September 30, 2017
|
212,176
|
$
6.53
|
|
|
|
Issued
|
100,000
|
7.50
|
|
|
|
Exercised
|
—
|
—
|
|
|
|
Forfeited
|
—
|
—
|
|
|
|
Outstanding
at December 31, 2017
|
312,176
|
$
6.84
|
4.3
|
$
—
|
|
|
|
|
|
|
|
Exercisable
at December 31, 2017
|
312,176
|
$
6.84
|
4.3
|
$
—
|
|
|
Number of shares
|
Weighted-average
exercise price
|
Expiration
|
|
|
|
|
|
|
Exercisable
at $7.80 per share
|
141,676
|
$
7.80
|
September
2021
|
|
Exercisable
at $4.00 per share
|
70,500
|
$
4.00
|
September
2022
|
|
Exercisable
at $7.50 per share
|
100,000
|
$
7.50
|
October
2022
|
|
|
312,176
|
6.84
|
|
|
|
Three Months Ended September 30, 2016
|
|||
|
|
Professional
Product Division
|
Licensing Division
|
Entertainment
Division
|
Total
|
|
Net
Sales
|
$
29,070
|
$
37,162
|
$
366,979
|
$
433,211
|
|
Net
Sales related party
|
$
-
|
$
-
|
$
254,545
|
$
254,545
|
|
Income
(loss) from Operations before Overhead
|
$
(360,753
)
|
$
(360,109
)
|
$
242,553
|
$
(478,309
)
|
|
Allocated
Corporate Overhead (a)
|
49,930
|
41,554
|
694,989
|
786,474
|
|
Net
Loss
|
$
(410,683
)
|
$
(401,663
)
|
$
(452,436
)
|
$
(1,264,782
)
|
|
|
|
|
|
|
|
Assets
|
$
4,587,741
|
$
5,792,671
|
$
4,918,581
|
$
15,298,993
|
|
|
Three Months Ended September 30, 2016
|
|||
|
|
Professional
Product Division
|
Licensing Division
|
Entertainment
Division
|
Total
|
|
Net
Sales
|
$
199,837
|
$
-
|
$
-
|
$
199,837
|
|
Income
(loss) from Operations before Overhead
|
$
(458,347
)
|
$
-
|
$
-
|
$
(458,347
)
|
|
Allocated
Corporate Overhead (a)
|
239,156
|
|
|
239,156
|
|
Net
Loss
|
$
(697,495
)
|
$
-
|
$
-
|
$
(697,495
)
|
|
|
|
|
|
|
|
Assets
|
$
2,688,852
|
-
|
-
|
$
2,688,852
|
|
Licensing
division
|
Founded in 2017 and first conceptualized by
kathy
ireland
® Worldwide, I'M1
is a lifestyle brand established to capitalize on potentially
lucrative licensing and co-branding opportunities with products
focused on millennials.
|
|
|
|
|||
|
|
|||
|
|
|
|
|
|
Entertainment
division
|
Also founded in 2017, EE1 was established to serve as a producer
and marketer of experiential entertainment including recordings,
film, TV, web and live events, and entertainment experiences. EE1
also provides brand management services including creative
development and marketing, brand strategy, and distribution
support.
|
|
|
|
|
|
|
|
kathy ireland
®
Health &
Wellness
|
Our newest business unit Level Health & Wellness was
established in September 2017, and has an exclusive license to
the
kathy
ireland
® Health &
Wellness™ brand. Its goal is to create a brand which will
include a wide variety of licensed products and services, targeted
to both Baby Boomers as well as millennials. This unit began
operating in fiscal 2018.
|
|
|
|
|
|
|
"
Beauty
belongs to everyone
"
|
Professional
products
division
|
Beauty & Pin-Ups, our first business unit is a professional
hair care line with a social conscience and launched its products
in 2015. We offer quality hair care products, including shampoos,
conditioners, styling aides and a patented styling tool, through an
expanding professional salon distribution network.
|
|
|
|
First Quarter
2018
|
First Quarter
2017
|
Change
|
|
|
(unaudited)
|
(unaudited)
|
|
|
|
|
|
|
|
Sales
|
$
448,793
|
$
422,173
|
|
|
Sales
related party
|
254,545
|
-
|
|
|
Total
gross sales
|
$
703,338
|
$
422,173
|
|
|
Allowances
|
(15,582
)
|
(222,336
)
|
|
|
Net
sales
|
$
433,211
|
$
199,837
|
|
|
Net
sales related party
|
254,545
|
-
|
|
|
Total
net sales
|
$
687,756
|
$
199,837
|
|
|
Costs
of sales
|
228,124
|
162,746
|
|
|
Gross
profit as a percentage of net sales
|
66.8
%
|
18.6
%
|
|
|
Operating
expenses
|
1,687,644
|
600,266
|
|
|
Other
expenses
|
69,770
|
132,320
|
|
|
Net
loss
|
$
(1,264,782
)
|
$
(697,495
)
|
|
|
Net
loss attributable to Level Brands, Inc. common
shareholders
|
$
(1,132,928
)
|
$
(634,479
)
|
|
|
|
First Quarter
2018
|
% of total
|
First Quarter
2017
|
% of total
|
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
Professional
products division
|
$
29,070
|
4.2
%
|
$
199,837
|
100
%
|
|
Licensing
division
|
37,162
|
5.4
%
|
0
|
%
|
|
Entertainment
division
|
621,524
|
90.4
%
|
0
|
%
|
|
Total
net sales
|
$
687,756
|
100
%
|
$
199,837
|
100
%
|
|
No.
|
|
Description
|
|
|
Agreement dated August 1, 2017 by and between Level Brands, Inc.
and Kure Corp. (incorporated by reference to Exhibit 10.62 to the
Current Report on Form 8-K as filed on December 12,
2017)
|
|
|
|
Agreement dated November 30, 2017 by and between Level Brands, Inc.
and Kure Corp. (incorporated by reference to Exhibit 10.63 to the
Current Report on Form 8-K as filed on December 12,
2017)
|
|
|
|
Revolving Line of Credit Loan Agreement dated December 11, 2017 by
and between Level Brands, Inc. and Kure Corp. (incorporated by
reference to Exhibit 10.64 to the Current Report on Form 8-K as
filed on December 12, 2017)
|
|
|
|
Security Agreement dated December 11, 2017 by and between Level
Brands, Inc. and Kure Corp. (incorporated by reference to Exhibit
10.65 to the Current Report on Form 8-K as filed on December 12,
2017)
|
|
|
|
Promissory Note in the principal amount of $500,000 dated December
11, 2017 due from Kure Corp. (incorporated by reference to Exhibit
10.66 to the Current Report on Form 8-K as filed on December 12,
2017)
|
|
|
|
License Agreement dated December 30, 2017 by and between Level
Brands, Inc. and Isodiol International, Inc. (incorporated by
reference to Exhibit 10.67 to the Current Report on Form 8-K as
filed on January 5, 2018)
|
|
|
|
Amendment dated January 30, 2018 to Wholesale License Agreement
between Level Brands, Inc. and kathy Ireland ® WorldWide Inc.
*
|
|
|
|
Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer
*
|
|
|
|
Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial
Officer*
|
|
|
|
Section 1350 Certification of Chief Executive Officer and Chief
Financial Officer*
|
|
|
101.INS
|
|
XBRL Instance Document*
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase *
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase *
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase *
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema *
|
|
*
|
|
Filed herewith
|
|
|
LEVEL BRANDS, INC.
|
|
|
|
|
|
|
February 14, 2018
|
By:
|
/s/ Martin A. Sumichrast
|
|
|
|
Martin A. Sumichrast, Chief Executive Officer, principal executive
officer
|
|
February 14, 2018
|
By:
|
/s/ Mark S. Elliott
|
|
|
|
Mark S. Elliott, Chief Operating Officer, Chief Financial Officer,
principal financial and accounting officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|